Detalles de la búsqueda
1.
Scientific rationale underpinning the development of biosimilar rituximab in hematological cancers and inflammatory diseases.
Future Oncol
; 15(36): 4223-4234, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31718287
2.
Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma.
Blood
; 121(2): 251-9, 2013 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23086756
3.
A novel systemically administered Toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models.
Int J Cancer
; 135(4): 820-9, 2014 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24390981
4.
A Retrospective Chart Review of Treatment Patterns and Overall Survival among a Cohort of Patients with Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom.
Cancers (Basel)
; 15(23)2023 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38067371
5.
Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies.
Front Cell Dev Biol
; 11: 1270398, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38020903
6.
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity.
Nat Rev Immunol
; 22(2): 124-138, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34211187
7.
Radiotherapy-Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery?
Cancers (Basel)
; 13(3)2021 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33530329
8.
Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries.
Cancers (Basel)
; 14(1)2021 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35008309
9.
Inhibition of DNA-PK with AZD7648 Sensitizes Tumor Cells to Radiotherapy and Induces Type I IFN-Dependent Durable Tumor Control.
Clin Cancer Res
; 27(15): 4353-4366, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34011558
10.
Understanding the Effects of Radiotherapy on the Tumour Immune Microenvironment to Identify Potential Prognostic and Predictive Biomarkers of Radiotherapy Response.
Cancers (Basel)
; 12(10)2020 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33008040
11.
Toll-Like Receptor Agonists and Radiation Therapy Combinations: An Untapped Opportunity to Induce Anticancer Immunity and Improve Tumor control.
Int J Radiat Oncol Biol Phys
; 108(1): 27-37, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32339645
12.
Evaluation of apoptosis imaging biomarkers in a genetic model of cell death.
EJNMMI Res
; 9(1): 18, 2019 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30783791
13.
The anti-PD-1 era - an opportunity to enhance radiotherapy for patients with bladder cancer.
Nat Rev Urol
; 15(4): 251-259, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29089607
14.
Cyclophosphamide inhibition of anti-CD40 monoclonal antibody-based therapy of B cell lymphoma is dependent on CD11b+ cells.
Cancer Res
; 65(16): 7493-501, 2005 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16103104
15.
The influence of radiation in the context of developing combination immunotherapies in cancer.
Ther Adv Vaccines Immunother
; 5(6): 115-122, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29998216
16.
Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade.
Clin Cancer Res
; 23(18): 5514-5526, 2017 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28533222
17.
Upregulation of meiosis-specific genes in lymphoma cell lines following genotoxic insult and induction of mitotic catastrophe.
BMC Cancer
; 6: 6, 2006 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-16401344
18.
Improving therapeutic activity of anti-CD20 antibody therapy through immunomodulation in lymphoid malignancies.
Leuk Lymphoma
; 57(6): 1269-80, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27050042
19.
Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T Cells.
Cancer Immunol Res
; 4(7): 621-630, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27241845
20.
Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy.
Oncotarget
; 7(13): 17035-46, 2016 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26959743